GlassScriptPhysician profile
Olivia T Logan
NPI 1972695849
$4,906.42
in general payments reported to CMS, 2019-2025
42 companies · $1,793 in 2025
The $1,793 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5.08 · 2022: $247 · 2023: $1,312 · 2024: $1,549 · 2025: $1,793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,463 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,462.70 |
| Education | $191.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $765.58 | 2023-2025 | Gemtesa, Orgovyx, Aptiom |
| Janssen Biotech, INC. | $472.84 | 2022-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $392.75 | 2022-2025 | Xtandi, Myrbetriq, Veozah |
| Ferring Pharmaceuticals INC. | $332.06 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $210.35 | 2022-2025 | Prolaris, Myrisk |
| Endo USA, INC. | $193.58 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $180.69 | 2023-2025 | Lynparza |
| 180 Medical, INC. | $179.40 | 2023-2025 | Gentlecath, Gentlecath Glide, Magic3 Intermittent Catheter |
| Teleflex LLC | $178.11 | 2022-2024 | Urolift |
| Convatec INC. | $174.44 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.25 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $164.89 | 2022-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $164.17 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Cequr Corporation | $104.88 | 2023 | Cequr Simplicity |
| Pfizer INC. | $92.65 | 2023-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $88.52 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $85.40 | 2023-2025 | Pylarify |
| Urogen Pharma, INC. | $83.40 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $81.63 | 2024-2025 | |
| Antares Pharma, INC. | $67.09 | 2024-2025 | Xyosted |
| Hollister Incorporated | $66.88 | 2024 | Vapro Plus Pocket |
| Immunitybio, INC. | $57.10 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $56.42 | 2024 | Bard Urinary Drainage Bag |
| Mission Pharmacal Company | $44.01 | 2022-2023 | Uribel |
| Agiliti Surgical, INC. | $43.22 | 2023 | Trinity, Sonablate, Soltive |
| Abbvie INC. | $42.83 | 2023-2025 | |
| Abc Home Medical Supply, INC. | $42.34 | 2024 | |
| Alnylam Pharmaceuticals INC. | $42.27 | 2023-2024 | Givlaari |
| Urovant Sciences INC | $40.30 | 2022 | |
| Laborie Medical Technologies Corp. | $37.72 | 2023 | |
| Tolmar, INC. | $32.26 | 2025 | Jatenzo, Eligard |
| Becton, Dickinson and Company | $26.54 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Calyxo, INC. | $25.09 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $24.50 | 2025 | |
| Accord Healthcare, INC. | $23.78 | 2025 | |
| Novartis Pharmaceuticals Corporation | $23.68 | 2024 | |
| Telix Pharmaceuticals | $23.54 | 2023 | Illuccix |
| Novo Nordisk INC | $22.01 | 2024 | |
| Olympus America INC. | $21.64 | 2025 | Itind System |
| Rochester Medical Corporation | $12.96 | 2022 | |
| Cycle Pharmaceuticals INC | $6.57 | 2024 | Tiopronin |
| Genentech USA, INC. | $5.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.